標(biāo)題: Titlebook: Cellular Cardiomyoplasty; Methods and Protocol Race L. Kao Book 2013 Springer New York 2013 Embryonic stem cells.Ventricular muscle cells.a [打印本頁(yè)] 作者: 佯攻 時(shí)間: 2025-3-21 17:07
書(shū)目名稱(chēng)Cellular Cardiomyoplasty影響因子(影響力)
作者: 蔑視 時(shí)間: 2025-3-21 21:20 作者: Inexorable 時(shí)間: 2025-3-22 03:04
Bio-hybrid Tissue Engineering for Cellular Cardiomyoplasty: Future Directions,ition, diastolic dysfunction is an important clinical problem in these cases because there is no medical or surgical specific treatment. Myocardial tissue engineering associating stem cells represent a new road and fresh hope for this heart failure population.作者: 尖酸一點(diǎn) 時(shí)間: 2025-3-22 07:21
Book 2013stem cells are totipotent cells that have the capability to differentiate into any type of cell in the body. In .Cellular Cardiomyoplasty: Methods and Protocols,? .expert researchers in the field detail many of the methods which are now commonly used to study cellular cardiomyoplasty. Methods and?te作者: 我吃花盤(pán)旋 時(shí)間: 2025-3-22 09:32
https://doi.org/10.1007/978-3-322-94495-5tigate two kinds of biocompatible nanoparticles (NPs) that can be useful for sustained delivery of single or multiple angiogenic growth factors to damaged sites, such as in myocardially infarcted heart to promote myocardial angiogenesis and reduce scar area.作者: 暫時(shí)過(guò)來(lái) 時(shí)間: 2025-3-22 13:07 作者: 暫時(shí)過(guò)來(lái) 時(shí)間: 2025-3-22 18:47 作者: Graves’-disease 時(shí)間: 2025-3-22 22:09
Decellularized Whole Heart for Bioartificial Heart,asic anatomy, vascular network, and critical ECM characteristics of the native heart. Such a cardiac ECM platform directly derived from nature itself might help us to better understand and reproduce cardiac biology and may even lay the grounds for the construction of a bioartificial heart in the future.作者: 增減字母法 時(shí)間: 2025-3-23 03:43
https://doi.org/10.1007/978-1-62703-511-8Embryonic stem cells; Ventricular muscle cells; adult progenitor cells; adult stem cells; angiogenesis; c作者: Flirtatious 時(shí)間: 2025-3-23 06:51
978-1-4939-6030-9Springer New York 2013作者: Communal 時(shí)間: 2025-3-23 10:31 作者: 生存環(huán)境 時(shí)間: 2025-3-23 17:08
Methods in Molecular Biologyhttp://image.papertrans.cn/c/image/223010.jpg作者: Genistein 時(shí)間: 2025-3-23 20:37
Cellular Cardiomyoplasty978-1-62703-511-8Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: forecast 時(shí)間: 2025-3-23 23:21 作者: Phenothiazines 時(shí)間: 2025-3-24 02:39 作者: rectum 時(shí)間: 2025-3-24 06:43 作者: Exhilarate 時(shí)間: 2025-3-24 13:18 作者: 隱藏 時(shí)間: 2025-3-24 16:48 作者: LINES 時(shí)間: 2025-3-24 22:38 作者: choleretic 時(shí)間: 2025-3-25 03:05 作者: 北極熊 時(shí)間: 2025-3-25 05:16 作者: Cupping 時(shí)間: 2025-3-25 09:26 作者: Paradox 時(shí)間: 2025-3-25 13:46 作者: BIPED 時(shí)間: 2025-3-25 19:09 作者: ingestion 時(shí)間: 2025-3-26 00:03
Two-Step Protocol for Isolation and Culture of Cardiospheres,作者: exceed 時(shí)間: 2025-3-26 04:04
Generation of Human iPSCs from Human Peripheral Blood Mononuclear Cells Using Non-integrative Senda作者: Sedative 時(shí)間: 2025-3-26 07:28 作者: 預(yù)測(cè) 時(shí)間: 2025-3-26 10:52 作者: corpuscle 時(shí)間: 2025-3-26 14:06
Immune Responses After Mesenchymal Stem Cell Implantation,作者: Cabg318 時(shí)間: 2025-3-26 19:02
Route of Delivery, Cell Retention, and Efficiency of Polymeric Microcapsules in Cellular Cardiomyop作者: 甜瓜 時(shí)間: 2025-3-26 21:35
Clinical Trials of Cardiac Repair with Adult Bone Marrow- Derived Cells,作者: Flavouring 時(shí)間: 2025-3-27 02:48 作者: intangibility 時(shí)間: 2025-3-27 08:08 作者: 地牢 時(shí)間: 2025-3-27 13:21
Angiogenic Nanodelivery Systems for Myocardial Therapy,ial therapy. Nanotechnology provides the tools to explore such frontiers of biomedical science at cellular level and thus offers unique features for potential application in the field of cardiac therapy. This chapter focuses on the methodology, based on the work done in our lab, to prepare and inves作者: 駭人 時(shí)間: 2025-3-27 15:43 作者: Confess 時(shí)間: 2025-3-27 21:23
Decellularized Whole Heart for Bioartificial Heart,hat—as for today—is not reproducible with any synthetic materials. Here, we describe a whole-heart decellularization approach through software-controlled automated coronary perfusion with standard decellularization detergents, enabling us to create native ECM-derived 3D templates that preserve the b作者: 收養(yǎng) 時(shí)間: 2025-3-27 23:37
5樓作者: 無(wú)聊點(diǎn)好 時(shí)間: 2025-3-28 05:07
5樓作者: RAFF 時(shí)間: 2025-3-28 06:53
5樓作者: defibrillator 時(shí)間: 2025-3-28 10:29
5樓作者: 含水層 時(shí)間: 2025-3-28 18:25
6樓作者: 大喘氣 時(shí)間: 2025-3-28 19:16
6樓作者: 黃油沒(méi)有 時(shí)間: 2025-3-29 02:38
6樓作者: Chagrin 時(shí)間: 2025-3-29 04:22
6樓作者: Abnormal 時(shí)間: 2025-3-29 09:33
7樓作者: 經(jīng)典 時(shí)間: 2025-3-29 15:22
7樓作者: 殺死 時(shí)間: 2025-3-29 16:11
7樓作者: 訓(xùn)誡 時(shí)間: 2025-3-29 23:05
7樓作者: Hemiplegia 時(shí)間: 2025-3-30 03:00
8樓作者: Immunization 時(shí)間: 2025-3-30 07:13
8樓作者: Biofeedback 時(shí)間: 2025-3-30 10:30
8樓作者: 削減 時(shí)間: 2025-3-30 13:53
9樓作者: 領(lǐng)帶 時(shí)間: 2025-3-30 20:07
9樓作者: Estimable 時(shí)間: 2025-3-30 22:33
9樓作者: 不可思議 時(shí)間: 2025-3-31 03:30
9樓作者: 不開(kāi)心 時(shí)間: 2025-3-31 06:00
10樓作者: Exploit 時(shí)間: 2025-3-31 10:00
10樓作者: 啜泣 時(shí)間: 2025-3-31 15:15
10樓作者: Lignans 時(shí)間: 2025-3-31 17:53
10樓
